首页> 外文期刊>Analytical methods >Chiral separation of methadone in exhaled breath condensate using capillary electrophoresis
【24h】

Chiral separation of methadone in exhaled breath condensate using capillary electrophoresis

机译:使用毛细管电泳呼吸呼吸缩合呼吸道的手性分离

获取原文
获取原文并翻译 | 示例
           

摘要

Breath analysis is a potential tool for monitoring the status of respiratory or systemic disorders. Non-invasive sampling techniques and reliable analytical methods for quantification of drugs of abuse are needed in therapeutic drug monitoring, clinical, sport medicine, and forensic applications. We assessed the effectiveness of exhaled breath condensate (EBC) as an alternative specimen to urine and blood in terms of ease of collection and matrix simplicity. A simple electrodriven separation method using a capillary electrophoresis system is presented for quantification of methadone enantiomers after direct injection of EBC in sample stacking mode. Stereoselective determination of methadone is needed because of the significant variation of the inter-subject enantiomeric ratio in patients receiving racemate. Our study is focused on the use of EBC as a readily available biological sample to monitor methadone levels with good patient compliance. However, the inter-correlation of methadone concentrations between EBC and serum or urine is not established and is investigated in the present work. Serum and urine samples from the patients were analyzed after microextraction using the developed method. The proposed method was validated according to US FDA guidelines over the concentration range of 0.15-5 mu g mL(-1) for each enantiomer of methadone. Inter- and intra-day precisions and accuracies were within the acceptable limit (20% for biological determinations). The recoveries ranged from 86 to 102% and the method was specific for routine analysis of methadone. Small-volume EBC samples from seven patients under methadone maintenance therapy were analyzed using the proposed method in which the concentrations of R- and S-enantiomers varied between 0.16 and 1.06 mu g mL(-1).
机译:呼气分析是监测呼吸或全身障碍状态的潜在工具。在治疗药物监测,临床,运动药物和法医应用中需要非侵入式采样技术和用于定量滥用药物的可靠分析方法。我们评估了呼气呼吸缩合物(EBC)作为尿液和血液的替代标本的有效性,易于收集和基质简单。使用毛细管电泳系统的简单电源分离方法用于在样品堆叠模式下直接注射EBC之后定量美沙酮对映异构体。需要立体选择性测定美沙酮,因为患者接受外星物的患者的受试者间对映的显着变化。我们的研究专注于使用EBC作为易于使用的生物样本,以监测患者均合规性的美沙酮水平。然而,未建立EBC和血清或尿液之间的美沙酮浓度的相互关联,并在本作工作中研究。使用开发方法在微萃取后分析来自患者的血清和尿液样本。根据美国FDA指南验证所提出的方法,对于每种甲基的每个对映体为0.15-5μgmml(-1)的浓度范围。间和日内的诊断和准确性在可接受的极限范围内(生物测定的20%)。回收率范围为86至102%,该方法特异于美沙酮常规分析。使用所提出的方法分析来自甲基维持治疗的7名患者的小体积EBC样品,其中R-和S-映体的浓度在0.16和1.06μg(-1)之间变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号